VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) Stock
VictoryShares US EQ Income Enhanced Volatility Wtd ETF Chart
Company Profile
Price: $64.20
Market Cap: $810.03M
Exchange: NASDAQ
CEO:
Sector: Financial Services
Industry: Asset Management - Income
Employees: -
Headquarters: None, DE
Business Summary
The fund seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets directly or indirectly in the securities included in the Nasdaq Victory US Large Cap 100 High Dividend Long/Cash Volatility Weighted Index. The index identifies the 100 highest dividend yielding stocks in the Nasdaq Victory US Large Cap 500 Volatility Weighted Index.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF News
CDC: A Mixed History Of Market Timing
VictoryShares US EQ Income Enhanced Volatility Wtd ETF is a defensive ETF seeking to mitigate risks in three ways: fundamental screening, volatility weighting and market timing. Market timing rules are unconventional and may be summarized as “sell first, then buy the dips”. They show mixed success, reducing volatility in 2020, but preventing recovery after the 2022 downturn.
Atossa Therapeutics Congratulates Board Director Dr. Tessa Cigler and Weill Cornell Medicine on CDC Grant to Enhance Breast Cancer Care
SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of breast cancer, extends its sincere congratulations to Dr. Tessa Cigler, esteemed Board Director at Atossa and Associate Professor of Clinical Medicine at Weill Cornell Medicine, and the Weill Cornell Medicine team for being awarded a five-year, $2.3 million grant from the Centers for Disease Control and Prevention (CDC). This grant will fund initiatives aimed at improving equitable access to care, quality of life, and survival outcomes for young breast cancer patients across New York City.
FHLB Dallas and Eight of its Members Award $283K to DFW Nonprofits
DALLAS--(BUSINESS WIRE)-- #affordablehousing--Representatives from the Federal Home Loan Bank of Dallas (FHLB Dallas) and eight of its members awarded $283,000 in grants to eight nonprofits in DFW. The awards were part of more than $1.2 million awarded to community groups through the Partnership Grant Program (PGP) and were celebrated during an event today at FHLB Dallas. “The PGP gives us the opportunity to partner with our financial institution members to connect with community organizations that may not have the.
CDC says 75 people affected in E. coli outbreak linked to McDonald's Quarter Pounders
It is the latest tally of people affected since the agency announced the outbreak on Tuesday, citing 49 cases and one death across 10 states. Health officials are closely examining the slivered onions used in the Quarter Pounder as a likely contaminant.
CDC'S ACIP Recommends Merck's CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--CDC'S ACIP Recommends Merck's CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older.
McDonald's E. Coli outbreak hits at least 10 states in ‘fast-moving' CDC investigation: Symptoms, update, and what to know
An E. coli outbreak has been linked to McDonald's restaurants in the U.S. heartland, causing the fast-food chain to temporarily remove a classic from its menu. The company has pulled the popular Quarter Pounder from restaurants in Colorado, Kansas, Utah, and Wyoming, along with portions of eight other states.
Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development
Quest to develop laboratory tests and support public health reporting and laboratory readiness for CDC's preparedness strategy; Company to introduce clinical testing for avian flu later this month based on one of the awards SECAUCUS, N.J. , Oct. 23, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been awarded several contracts by the U.S. Centers for Disease Control and Prevention (CDC) to support testing and sustained laboratory readiness for two emerging infectious diseases recently identified in people in the Americas.
President Museveni pledges more support to Africa Centres for Disease Control and Prevention
President Yoweri Kaguta Museveni has reiterated his commitment to support the agenda of the Africa Centres for Disease Control and Prevention (CDC) to strengthen the capacity of African health institutions to deal with disease threats. The President made the commitment on Friday, October 18, 2024, while meeting a delegation from the Africa-CDC led by their […] The post President Museveni pledges more support to Africa Centres for Disease Control and Prevention appeared first on Watchdog Uganda...
'Eric is lying': Experts catch Trump's son spreading false statistic on Fox News
Donald Trump's son was caught on Fox News delivering grossly inflated numbers of deaths due to fentanyl. According to Eric Trump, over 300,000 kids have been killed this year. The video was shared by Immigration Council fellow Aaron Reichlin-Melnick, who said it was wildly off. "Fentanyl overdoses in 2022 were ~75,000," he posted, citing Center for Disease Control (CDC) numbers. Read Also: Inside Big Pharma's Republican cash grabHe pointed out that the best news from the numbers, however, is tha...
CDC: A Value Dividend Play For When Stocks Go Down Hard
Active management aims to beat benchmarks but often struggles; VictoryShares US EQ Income Enhanced Volatility Wtd ETF offers a disciplined, risk-managed approach focusing on high-yield, stable large-cap stocks. The CDC ETF's unique volatility-weighted methodology and ability to move to cash during market drops provide a smoother ride and potential protection against big losses. The fund's sector allocation leans towards dividend-paying sectors like Utilities, Financials, and Energy, with a lower tech allocation, offering a diversified approach.
FendX Discusses Recent CDC Report on the Rise of Six Superbug Infections in the US
CDC reports burden of six hard-to-treat superbugs increased by a combined 20% in 2021 and 2022 compared with 2019 CDC call to action for more effective infection prevention and control, and the need for innovative prevention strategies FendX's goal is to develop innovative solutions using their nanotechnology that will contribute to reducing the spread of superbugs Oakville, Ontario--(Newsfile Corp. - July 30, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings to reduce the spread of pathogens, highlights a new report from the Centre of Disease Control ("CDC") published on July 16, 2024 highlighting the increased incidence of infections caused by six antibiotic-resistant bacteria (commonly know as 'superbugs') and emphasized the need to invest in the prevention-focused public health initiatives that can effectively control their spread. The new CDC report highlighted a combined 20% increase in infection rate from six difficult to treat superbugs in 2021 and 2022 compared to 2019.
What are the 5 Most Common Personal Injuries?
In the US, injury is the leading cause of death for people under 45 years old, as per the collected 2022 data from the Centers for Disease Control and Prevention (CDC). Injuries as you know, it also create serious medical issues in people of all ages. Furthermore, this normally including injury and in some poisoning-related […] The post What are the 5 Most Common Personal Injuries? appeared first on QuintDaily...
VictoryShares US EQ Income Enhanced Volatility Wtd ETF Earnings
This section highlights VictoryShares US EQ Income Enhanced Volatility Wtd ETF's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|
Financial Statements
Access annual & quarterly financial statements for VictoryShares US EQ Income Enhanced Volatility Wtd ETF, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown |
|---|
| Revenue |
| Cost of Revenue |
| Gross Profit |
| Gross Profit Ratio |
| Research and Development Expenses |
| General and Administrative Expenses |
| Selling and Marketing Expenses |
| Selling General and Administrative Expenses |
| Other Expenses |
| Operating Expenses |
| Cost and Expenses |
| Interest Income |
| Interest Expense |
| Depreciation and Amortization |
| EBITDA |
| EBITDA Ratio |
| Operating Income |
| Operating Income Ratio |
| Total Other Income Expenses Net |
| Income Before Tax |
| Income Before Tax Ratio |
| Income Tax Expense |
| Net Income |
| Net Income Ratio |
| EPS |
| EPS Diluted |
| Weighted Average Shares Outstanding |
| Weighted Average Shares Outstanding Diluted |
| SEC Filing |
Income Statement Charts
| Breakdown |
|---|
| Revenue |
| Cost of Revenue |
| Gross Profit |
| Gross Profit Ratio |
| Research and Development Expenses |
| General and Administrative Expenses |
| Selling and Marketing Expenses |
| Selling General and Administrative Expenses |
| Other Expenses |
| Operating Expenses |
| Cost and Expenses |
| Interest Income |
| Interest Expense |
| Depreciation and Amortization |
| EBITDA |
| EBITDA Ratio |
| Operating Income |
| Operating Income Ratio |
| Total Other Income Expenses Net |
| Income Before Tax |
| Income Before Tax Ratio |
| Income Tax Expense |
| Net Income |
| Net Income Ratio |
| EPS |
| EPS Diluted |
| Weighted Average Shares Outstanding |
| Weighted Average Shares Outstanding Diluted |
| SEC Filing |
Annual Balance Sheet
| Breakdown |
|---|
| Cash and Cash Equivalents |
| Short Term Investments |
| Cash and Short Term Investments |
| Net Receivables |
| Inventory |
| Other Current Assets |
| Total Current Assets |
| Property Plant Equipment Net |
| Goodwill |
| Intangible Assets |
| Goodwill and Intangible Assets |
| Long Term Investments |
| Tax Assets |
| Other Non-Current Assets |
| Total Non-Current Assets |
| Other Assets |
| Total Assets |
| Account Payables |
| Short Term Debt |
| Tax Payables |
| Deferred Revenue |
| Other Current Liabilities |
| Total Current Liabilities |
| Long Term Debt |
| Deferred Revenue Non-Current |
| Deferred Tax Liabilities Non-Current |
| Other Non-Current Liabilities |
| Total Non-Current Liabilities |
| Other Liabilities |
| Total Liabilities |
| Preferred Stock |
| Common Stock |
| Retained Earnings |
| Accumulated Other Comprehensive Income Loss |
| Other Total Stockholders Equity |
| Total Stockholders Equity |
| Total Equity |
| Total Liabilities and Stockholders Equity |
| Minority Interest |
| Total Liabilities and Total Equity |
| Total Investments |
| Total Debt |
| Net Debt |
Balance Sheet Charts
| Breakdown |
|---|
| Cash and Cash Equivalents |
| Short Term Investments |
| Cash and Short Term Investments |
| Net Receivables |
| Inventory |
| Other Current Assets |
| Total Current Assets |
| Property Plant Equipment Net |
| Goodwill |
| Intangible Assets |
| Goodwill and Intangible Assets |
| Long Term Investments |
| Tax Assets |
| Other Non-Current Assets |
| Total Non-Current Assets |
| Other Assets |
| Total Assets |
| Account Payables |
| Short Term Debt |
| Tax Payables |
| Deferred Revenue |
| Other Current Liabilities |
| Total Current Liabilities |
| Long Term Debt |
| Deferred Revenue Non-Current |
| Deferred Tax Liabilities Non-Current |
| Other Non-Current Liabilities |
| Total Non-Current Liabilities |
| Other Liabilities |
| Total Liabilities |
| Preferred Stock |
| Common Stock |
| Retained Earnings |
| Accumulated Other Comprehensive Income Loss |
| Other Total Stockholders Equity |
| Total Stockholders Equity |
| Total Equity |
| Total Liabilities and Stockholders Equity |
| Minority Interest |
| Total Liabilities and Total Equity |
| Total Investments |
| Total Debt |
| Net Debt |
Annual Cash Flow
| Breakdown |
|---|
| Net Income |
| Depreciation and Amortization |
| Deferred Income Tax |
| Stock Based Compensation |
| Change in Working Capital |
| Accounts Receivables |
| Inventory |
| Accounts Payables |
| Other Working Capital |
| Other Non Cash Items |
| Net Cash Provided by Operating Activities |
| Investments in Property Plant and Equipment |
| Acquisitions Net |
| Purchases of Investments |
| Sales Maturities of Investments |
| Other Investing Activities |
| Net Cash Used for Investing Activities |
| Debt Repayment |
| Common Stock Issued |
| Common Stock Repurchased |
| Dividends Paid |
| Other Financing Activities |
| Net Cash Used Provided by Financing Activities |
| Effect of Forex Changes on Cash |
| Net Change in Cash |
| Cash at End of Period |
| Cash at Beginning of Period |
| Operating Cash Flow |
| Capital Expenditure |
| Free Cash Flow |
Cash Flow Charts
| Breakdown |
|---|
| Net Income |
| Depreciation and Amortization |
| Deferred Income Tax |
| Stock Based Compensation |
| Change in Working Capital |
| Accounts Receivables |
| Inventory |
| Accounts Payables |
| Other Working Capital |
| Other Non Cash Items |
| Net Cash Provided by Operating Activities |
| Investments in Property Plant and Equipment |
| Acquisitions Net |
| Purchases of Investments |
| Sales Maturities of Investments |
| Other Investing Activities |
| Net Cash Used for Investing Activities |
| Debt Repayment |
| Common Stock Issued |
| Common Stock Repurchased |
| Dividends Paid |
| Other Financing Activities |
| Net Cash Used Provided by Financing Activities |
| Effect of Forex Changes on Cash |
| Net Change in Cash |
| Cash at End of Period |
| Cash at Beginning of Period |
| Operating Cash Flow |
| Capital Expenditure |
| Free Cash Flow |
VictoryShares US EQ Income Enhanced Volatility Wtd ETF Stock Forecast
Analyst ratings, price targets, and earnings estimates for CDC.
CDC Stock 12 Month Forecast
$57.00
Based on 1 analysts in the last year
Recent Price Targets
Recommendation Trends
Latest Price Target Updates
| Date | Analyst | Firm | Price Target | Price When Posted | Upside |
|---|---|---|---|---|---|
| Feb 22, 2025 | New Street | $57.00 | $65.88 | -13.5% |
VictoryShares US EQ Income Enhanced Volatility Wtd ETF Dividends
Explore VictoryShares US EQ Income Enhanced Volatility Wtd ETF's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
-
Dividend Payout Ratio
-
Dividend Paid & Capex Coverage Ratio
x
VictoryShares US EQ Income Enhanced Volatility Wtd ETF Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.20589 | $0.20589 | March 10, 2025 | March 10, 2025 | March 11, 2025 | March 07, 2025 |
| $0.13307 | $0.13307 | February 07, 2025 | February 07, 2025 | February 10, 2025 | February 06, 2025 |
| $0.007166 | $0.007166 | January 08, 2025 | January 08, 2025 | January 09, 2025 | January 07, 2025 |
| $0.4142 | $0.4142 | December 12, 2024 | December 12, 2024 | December 13, 2024 | December 11, 2024 |
| $0.12099 | $0.12099 | November 07, 2024 | November 07, 2024 | November 08, 2024 | November 06, 2024 |
| $0.15118 | $0.15118 | October 08, 2024 | October 08, 2024 | October 09, 2024 | October 07, 2024 |
| $0.2465 | $0.2465 | September 11, 2024 | September 11, 2024 | September 12, 2024 | September 10, 2024 |
| $0.13189 | $0.13189 | August 08, 2024 | August 08, 2024 | August 09, 2024 | August 07, 2024 |
| $0.14254 | $0.14254 | July 10, 2024 | July 10, 2024 | July 11, 2024 | July 09, 2024 |
| $0.22161 | $0.22161 | June 12, 2024 | June 12, 2024 | June 13, 2024 | June 11, 2024 |
| $0.073906 | $0.073906 | May 09, 2024 | May 10, 2024 | May 13, 2024 | May 08, 2024 |
| $0.15972 | $0.15972 | April 11, 2024 | April 12, 2024 | April 15, 2024 | April 10, 2024 |
| $0.26338 | $0.26338 | March 11, 2024 | March 12, 2024 | March 13, 2024 | March 08, 2024 |
| $0.10534 | $0.10534 | February 09, 2024 | February 12, 2024 | February 13, 2024 | February 08, 2024 |
| $0.43654 | $0.43654 | December 18, 2023 | December 19, 2023 | December 20, 2023 | December 15, 2023 |
| $0.22198 | $0.22198 | November 08, 2023 | November 09, 2023 | November 10, 2023 | November 07, 2023 |
| $0.3052 | $0.3052 | October 11, 2023 | October 12, 2023 | October 13, 2023 | October 10, 2023 |
| $0.18697 | $0.18697 | September 06, 2023 | September 07, 2023 | September 08, 2023 | September 05, 2023 |
| $0.20772 | $0.20772 | August 08, 2023 | August 09, 2023 | August 10, 2023 | August 07, 2023 |
| $0.1914 | $0.1914 | July 10, 2023 | July 11, 2023 | July 12, 2023 | July 07, 2023 |
Peers: Asset Management - Income
This section provides companies within the same sector, on the same exchange, and of similar market capitalization, allowing comparisons of key financial indicators among peers.
| Company | Market Cap | Price | EPS | P/E Ratio | P/B Ratio |
|---|---|---|---|---|---|
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
|
$440.30M | $67.53 | $ | $ | $ |
VictoryShares US 500 Volatility Wtd ETF
CFA
|
$539.83M | $83.48 | $ | $ | $ |
VictoryShares US Discovery Enhanced Volatility Wtd ETF
CSF
|
$41.76M | $51.45 | $ | $ | $ |
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
|
$11.50B | $56.71 | $ | $ | $ |
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
|
$29.87M | $32.04 | $ | $ | $ |
Related Metrics
Explore detailed financial metrics and analysis for CDC.